United States · FDA National Drug Code directory
Blowfish
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 75920-0464_471d9709-2a0c-f8e7-e063-6294a90af637
- Product NDC
- 75920-0464
- Form
- TABLET, EFFERVESCENT
- Composition / generic term
- Aspirin, Caffeine
- Labeler
- Rally Labs LLC
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20110723
- Source listing expiry
- 20261231
Source-listed ingredients
- ASPIRIN — 500 mg/1
- CAFFEINE — 60 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 TABLET, EFFERVESCENT in 1 BOX (75920-0464-1) · 75920-0464-1
- 20 TABLET, EFFERVESCENT in 1 BAG (75920-0464-2) · 75920-0464-2
- 40 TABLET, EFFERVESCENT in 1 BAG (75920-0464-4) · 75920-0464-4
- 20 TABLET, EFFERVESCENT in 1 BOX (75920-0464-5) · 75920-0464-5
- 4 TABLET, EFFERVESCENT in 1 BOX (75920-0464-6) · 75920-0464-6
- 20 TABLET, EFFERVESCENT in 1 BOX (75920-0464-7) · 75920-0464-7
- 12 TABLET, EFFERVESCENT in 1 BOX (75920-0464-8) · 75920-0464-8
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →